AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus ...
The Lupus Foundation of America is proud to share its 2025 Impact Report, which highlights the progress we’ve made together ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback